| Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry HA Ghofrani, MAG Sanchez, M Humbert, D Pittrow, G Simonneau, H Gall, ... Respiratory medicine 178, 106220, 2021 | 34 | 2021 |
| A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance V Chubuchny, NR Pugliese, C Taddei, E Poggianti, V Spini, A Barison, ... ESC Heart Failure 8 (2), 1216-1229, 2021 | 28 | 2021 |
| Accuracy of chest radiography in predicting pulmonary hypertension: a case-control study M Miniati, S Monti, E Airò, R Pancani, B Formichi, C Bauleo, C Marini Thrombosis Research 133 (3), 345-351, 2014 | 26 | 2014 |
| Riociguat treatment in patients with pulmonary arterial hypertension: final safety data from the EXPERT registry MM Hoeper, MAG Sanchez, M Humbert, D Pittrow, G Simonneau, H Gall, ... Respiratory medicine 177, 106241, 2021 | 19 | 2021 |
| Global right heart assessment with speckle-tracking imaging improves the risk prediction of a validated scoring system in pulmonary arterial hypertension D Stolfo, S Albani, F Biondi, A De Luca, G Barbati, L Howard, FL Giudice, ... Journal of the American Society of Echocardiography 33 (11), 1334-1344. e2, 2020 | 17 | 2020 |
| Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension C Marini, B Formichi, C Bauleo, C Michelassi, E Airò, G Rossi, C Giuntini Internal and emergency medicine 11, 941-952, 2016 | 8 | 2016 |
| Echocardiographic biventricular coupling index to predict precapillary pulmonary hypertension S Albani, D Stolfo, A Venkateshvaran, V Chubuchny, F Biondi, A De Luca, ... Journal of the American Society of Echocardiography 35 (7), 715-726, 2022 | 7 | 2022 |
| Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension D Stolfo, D Barbisan, P Ameri, CM Lombardi, S Monti, M Driussi, ... The Journal of Heart and Lung Transplantation 42 (8), 1082-1092, 2023 | 6 | 2023 |
| Cardiac tamponade due to apixaban therapy in patient with unknown pericardial hemangioma F Sbrana, F Mannucci, E Airò, GD Aquaro, R Prediletto Internal and Emergency Medicine 13 (2), 297-299, 2018 | 6 | 2018 |
| Cardio-pulmonary involvement in pulmonary arterial hypertension: A perfusion and innervation scintigraphic evaluation A Gimelli, NR Pugliese, M Bertasi, E Airò, C Bauleo, B Formichi, ... Journal of Nuclear Cardiology 28 (2), 546-556, 2021 | 4 | 2021 |
| Obstructive sleep apneas and cardiovascular diseases V Castiglione, P Morfino, F Gentile, E Airò, C Passino, A Giannoni, ... Giornale Italiano di Cardiologia (2006) 24 (12), 979-989, 2023 | 2 | 2023 |
| Gaps in evidence in the management of patients with intermediate-risk pulmonary arterial hypertension: Considerations following the ESC/ERS 2022 guidelines M D'Alto, R Badagliacca, E Airò, P Ameri, P Argiento, A Garascia, ... Vascular Pharmacology, 107374, 2024 | 1 | 2024 |
| Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype M Toma, G Savonitto, CM Lombardi, E Airò, M Driussi, P Gentile, ... Clinical Research in Cardiology, 1-12, 2024 | 1 | 2024 |
| The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease A Aimo, I Tono, E Benelli, P Morfino, G Panichella, AL Damone, MF Speltri, ... Journal of Cardiovascular Medicine 25 (4), 294-302, 2024 | | 2024 |
| Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension G Savonitto, D Barbisan, P Ameri, CM Lombardi, S Monti, M Driussi, ... ESC Heart Failure, 2024 | | 2024 |
| Phenotype and outcome correlates of high dose loop diuretics in type 1 pulmonary hypertension D Stolfo, D Barbisan, F Lo Giudice, CM Lombardi, E Airo', M Driussi, ... European Heart Journal 44 (Supplement_2), ehad655. 1956, 2023 | | 2023 |
| Risk assessment according to the presence of left heart disease phenotype in pulmonary arterial hypertension patients: a multicenter cohort study M Toma, D Barbisan, CM Lombardi, E Airo, M Driussi, P Gentile, ... European Heart Journal 44 (Supplement_2), ehad655. 2008, 2023 | | 2023 |
| Pulmonary hypertension clinical pathway: ANMCO Tuscany Board model G Spaziani, S Monti, L Misuraca, E Airò, AM Traini, C Bauleo, ML Canale, ... Giornale Italiano di Cardiologia (2006) 24 (3), 178-187, 2023 | | 2023 |
| 152 PERFORMANCE OF RISK STRATIFICATION SCORES AND ROLE OF COMORBIDITIES IN OLDER VS YOUNGER PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION D Stolfo, D Barbisan, P Ameri, CM Lombardi, S Monti, M Driussi, ... European Heart Journal Supplements 24 (Supplement_K), suac121. 282, 2022 | | 2022 |
| A combined measure of pulmonary vascular resistence and compliance variations in Pulmonary Hypertension (PH) E Airò, C Bauleo, R Prediletto, B Formichi, I Pavlickova, M Raciti, S Monti European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
bruno formichiFondazione G. Monasterio CNR/Regione ToscanaVerified email at cnr.it
